Screener
Neuronetics STIM Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $19.2M+75.0% | $13.21M-34.7% | $28.13M+52.4% | $27.97M+34.0% | $10.97M-74.3% | ||
| $15.96M-38.9% | $15.81M-39.7% | $16.47M-29.5% | $18.69M+11.1% | $26.12M+52.3% | ||
| $5.5M+11.3% | $4.72M+15.9% | $4.33M+1.9% | $4.32M-12.9% | $4.94M-19.5% | ||
| $53.23M-5.2% | $47.18M-22.2% | $61.55M+5.9% | $64.89M+21.4% | $56.14M-25.6% | ||
| $3.46M-34.9% | $3.87M-33.7% | $4.47M-28.5% | $4.94M+201% | $5.32M+208% | ||
| $23.62M+23.8% | $23.62M+26.8% | $23.62M+26.8% | $22.66M— | $19.08M— | ||
| $17.42M-7.7% | $17.79M-7.6% | $18.15M-7.4% | $18.51M— | $18.88M— | ||
| $131.53M-2.3% | $125.44M-11.7% | $141.55M+0.5% | $145.47M+96.3% | $134.65M+39.1% | ||
| $12.42M+27.7% | $11.43M+34.8% | $10.74M-3.1% | $11.57M+251% | $9.73M+137% | ||
| $58K— | $58K— | $48K+2,300% | —— | —— | ||
| $28.31M+1.8% | $28.29M+13.9% | $30.52M-2.4% | $28.94M+71.3% | $27.8M-5.0% | ||
| $61.52M+10.8% | $61.3M+10.8% | $65.81M+19.3% | $65.67M+42.8% | $55.54M+20.4% | ||
| $109.89M+6.5% | $108.38M+5.8% | $115.31M+5.7% | $114.11M+76.3% | $103.14M+33.2% | ||
| $762K+15.3% | $696K+5.8% | $690K+23.9% | $685K+126% | $661K+120% | ||
| -$473.15M-6.9% | -$469.58M-8.6% | -$458.79M-9.3% | -$451.63M-10.9% | -$442.58M-12.4% | ||
| $17.85M-34.2% | $13.27M-62.6% | $22.38M-19.2% | $27.36M+192% | $27.15M+40.0% | ||
| $131.53M-2.3% | $125.44M-11.7% | $141.55M+0.5% | $145.47M+96.3% | $134.65M+39.1% |
FAQ
- What are Neuronetics's total assets?
- Neuronetics (STIM) holds $131.5M in total assets, down 2.3% year over year.
- How much debt does Neuronetics have?
- Neuronetics carries $86.5M in total debt against $17.9M of shareholders' equity, a debt-to-equity ratio of 4.85.
- How much cash does Neuronetics have?
- Neuronetics holds $19.2M in cash and equivalents.
- Can Neuronetics cover its short-term obligations?
- Its current ratio is 1.88 — current assets exceed current liabilities.
- Where does Neuronetics's balance sheet data come from?
- Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
